Results 101 to 110 of about 393,880 (203)

Mumps vaccine effectiveness in primary schools and households, the Netherlands, 2008

open access: yes, 2012
Item does not contain fulltextTo estimate the mumps vaccine effectiveness (VE) during a large genotype D mumps outbreak, we conducted a cross-sectional study in eight primary schools and associated households in the Netherlands.
Schipper, M.   +11 more
core   +1 more source

Outbreak of mumps associated with poor vaccine efficacy - Oporto Portugal 1996

open access: yes, 1998
Vaccination against mumps in Portugal began in 1987, with the introduction of the combined measles, mumps, and rubella vaccine (MMR) in the national vaccination programme (Programa Nacional de Vacinação: PNV) for both sexes at 15 months. In November 1990,
G Gonçalves   +2 more
core   +1 more source

Genetic associations with mumps and rubella antibody response after MMR vaccination in 6- and 15-month-old children

open access: yesVaccine: X
Background: Measles, mumps, and rubella (MMR) vaccines have significantly improved public health worldwide. However, variation in vaccine response among immunized individuals poses a threat to both individual protection and herd immunity.
Jesper Kiehn Sørensen   +10 more
doaj   +1 more source

Understanding MMR vaccine safety [PDF]

open access: yes
Last updated February 2013CDC recommends two doses of the measles, mumps, and rubella vaccine (MMR) for children because it protects them against dangerous, even deadly, diseases.CS233434Nvacsafe-mmr-color-office ...

core  

Post-vaccination Mumps. An Infrequent Adverse Event after Wide MMR Vaccination During an Outbreak of Measles in Mexico

open access: yesAntimicrobial Stewardship & Healthcare Epidemiology
Background: Measles cases increased significantly in the Americas in 2025; the region lost its measles-free status due to the return of endemic transmission in Canada, Mexico, and the U.S., primarily driven by low vaccination rates among unvaccinated or ...
Diana Vilar-Compte   +7 more
doaj   +1 more source

MMR vaccine (measles, mumps, rubella) : what you need to know

open access: yes
MMR vaccine can prevent measles, mumps, and rubella.mmr.pdf1. Why get vaccinated? -- 2. MMR vaccine -- 3. Talk with your health care provider -- 4. Risks of a vaccine reaction-- 5. What if there is a serious problem? \u2013 6. The National Vaccine Injury

core  

Reactogenicity and immunogenicity of a new measles-mumps-rubella vaccine containing RIT 4385 mumps virus strain in healthy Turkish children

open access: yesThe Turkish Journal of Pediatrics, 2000
A total of 44 children aged between 15-18 months were randomly vaccinated either with a new measles-mumps-rubella (MMR) vaccine (Priorix, SmithKline Beecham) or a commercially available MMR vaccine (MMR-II, Merck) to compare the reactogenicity and
G Kanra, M Ceyhan, E Ozmert
doaj  

Parotitis Cases Due to Measles-Mumps-Rubella Vaccine

open access: yes, 2010
We report ten cases with parotitis following the measles-mumpsrubella (MMR) vaccine which contains Edmonston-Zagreb measles strain, Leningrad-Zagreb mumps strain and Wistar RA 27/3 rubella strain (Tresivac (R), Serum Institute of India, India).
Levent Gorenek   +11 more
core   +1 more source

MMR vaccine (measles, mumps, rubella) : what you need to know [Dari]

open access: yes
MMR vaccine (measles, mumps, rubella) : what you need to know [Dari]MMR VIS \u2013 Dari (8/6/21)dari_mmr ...

core  

Home - About - Disclaimer - Privacy